1-phenyl-4-n-butyl-3,5-dioxopyrazolidine,
mofebutazone,
Mofesal N,
monophenylbutazone,
monophenylbutazone, sodium salt,
Mofebutazone,
Monophenylbutazone,
2210-63-1,
4-butyl-1-phenylpyrazolidine-3,5-dione,
Mophebutazone,
Mobutazone,
Mobutazon,
Mobuzon,
Mozol,
Monorheumetten,
Arcobutine,
Corbuton,
Monobutyl,
Reumatox,
Monazan,
Monofen,
Monomil,
Monozon,
Arcomonol tablets,
Mofebutazonum,
2 Fdbp,
Mofebutazona,
4-Butyl-1-phenyl-3,5-dioxopyrazolidine,
4-Butyl-1-phenyl-3,5-pyrazolidinedione,
2-Phenyl-3,5-dihydroxy-4-butylpyrazolidine,
NSC 73725,
Mofebutazonum [INN-Latin],
Mofebutazona [INN-Spanish],
MLS002693879,
CHEBI:76252,
3,5-PYRAZOLIDINEDIONE, 4-BUTYL-1-PHENYL-,
EINECS 218-641-1,
BRN 0213056,
1-Phenyl-4-butyl-3,5-pyrazolidinedione,
4-Butyl-3,5-diketo-1-phenylpyrazolidine,
W-107503,
Mofesal,
Monazon,
mofebutazon,
Monazone,
Monophenyl butazone,
Monazone (TN),
Mofebutazone (INN),
Mofebutazone [Ligerium],
1-phenyl-4-n-butyl-3,5-dioxopyrazolidine,
AC1Q2VLG,
AC1Q2VLH,
Mofebutazone [INN:DCF],
3, 4-butyl-1-phenyl-,
AC1L28DR,
SCHEMBL23506,
CHEMBL1892201,
DTXSID4023331,
REOJLIXKJWXUGB-UHFFFAOYSA-N,
HMS3094E11,
NSC73725,
NSC-73725,
AKOS015962258,
ACM2210631,
API0010057,
MCULE-9290585539,
SMR001559820,
AX8140236,
LS-128619,
D07262,
Butazone,
nabumetone,
Mofesal N,
UNII-SPW36WUI5Z,
SPW36WUI5Z,
monophenylbutazone, sodium salt,
C13H16N2O2,
ACN-S002482,
CID16639,
3,5-Pyrazolidinedione,4-butyl-1-phenyl-,
5-24-05-00400 (Beilstein Handbook Reference),
C002374,